PARVUS THERAPEUTICS
Parvus Therapeutics is a novel class of therapeutics to reverse autoimmune disease without impairing normal immunity.
PARVUS THERAPEUTICS
Social Links:
Industry:
Biotechnology Health Care Therapeutics Wellness
Address:
South San Francisco, California, United States
Country:
United States
Website Url:
http://www.parvustherapeutics.com
Total Employee:
11+
Status:
Active
Contact:
415-805-8251
Email Addresses:
[email protected]
Technology used in webpage:
SPF Amazon Google Maps API Amazon Route 53 Barracuda Networks
Official Site Inspections
http://www.parvustherapeutics.com
- Host name: s3-website-us-east-1.amazonaws.com
- IP address: 52.216.57.165
- Location: Ashburn United States
- Latitude: 39.0481
- Longitude: -77.4728
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20149
More informations about "Parvus Therapeutics"
Company - Parvus Therapeutics Inc.
About Parvus At Parvus, we are developing a pipeline of novel proprietary pMHC nanomedicine drug candidates (a.k.a. NavacimsTM) which trigger endogenous generation of regulatory T โฆSee details»
Parvus Therapeutics - Crunchbase Company Profile & Funding
Organization. Parvus Therapeutics . Connect to CRM . Save . Summary. People. Technology. Signals & News. Similar Companies. About. Parvus Therapeutics is a novel class of โฆSee details»
Parvus Therapeutics Company Profile | Management and
Parvus Therapeutics Profile and History. Parvus Therapeutics Inc. (Parvus) is a privately held biopharmaceutical company developing Navacims, a platform technology based on โฆSee details»
Parvus Therapeutics Company Profile 2024: Valuation, Funding ...
Parvus Therapeutics is headquartered in South San Francisco, CA. What is the size of Parvus Therapeutics? Parvus Therapeutics has 22 total employees. What industry is Parvus โฆSee details»
Parvus Therapeutics Inc Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Parvus Therapeutics Inc of Calgary, AB. Get the latest business insights from Dun & Bradstreet.See details»
Org Chart Parvus Therapeutics - The Official Board
Organizational Chart of Parvus Therapeutics. Parvus Therapeutics www.parvustx.com. has 11 executives +1 415 805 8251; Add an executive. Parvus Therapeutics News . Anything โฆSee details»
Parvus Therapeutics Company Profile - Office Locations ... - Craft
Parvus Therapeutics is a company specializing in disease-modifying therapeutics for autoimmune diseases. It develops Navacims therapeutics that target disease-causing effector T cells. โฆSee details»
Parvus Therapeutics - VentureRadar
Parvus is pioneering a novel class of disease-modifying therapeutics โ Navacimsโข โ that are designed to reverse autoimmune disease by selectively... ... Find ...See details»
Parvus Therapeutics headquarters and office locations - Craft
Parvus Therapeutics is headquartered in South San Francisco, 800 Dubuque Ave, United States, and has 1 office location.See details»
Parvus Therapeutics - Contacts, Employees, Board Members
Organization. Parvus Therapeutics . Connect to CRM . Save . Summary. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 2. Contacts 9. ... Parvus โฆSee details»
Parvus Therapeutics - Products, Competitors, Financials, โฆ
Parvus Therapeutics is a biopharmaceutical company focused on developing treatments for autoimmune diseases. The company's main innovation, Navacims, is a platform technology โฆSee details»
Careers - Parvus Therapeutics Inc.
We are seeking extraordinary and ambitious individuals who share our drive and desire to transform medicineSee details»
Parvus Therapeutics Inc. | Insights
Mar 29, 2024 Already A Biomedtracker Subscriber? You have access to the full company record through your subscription.See details»
Genentech signs deal with Parvus to tackle inflammatory diseases
May 17, 2019 Canadaโs Parvus Therapeutics has signed a deal with Rocheโs Genentech unit to develop, manufacture and market drugs for inflammatory bowel disease, autoimmune liver โฆSee details»
Research Money Inc โ Organizations โ Parvus Therapeutics
Organization: Parvus Therapeutics Opinion Leader โ The Rise of the Rest: Building a high-performance innovation ecosystem in Calgary. October 5th, 2022. Calgary demonstrates the โฆSee details»
Parvus Therapeutics and Ardena Enter Agreement for Tech โฆ
Nov 19, 2021 Parvus Therapeutics and Ardena Enter Agreement for Tech Transfer, Scale-Up and GMP Manufacturing of Navacim Nanoparticles. SOUTH SAN FRANCISCO, CALIFORNIA โฆSee details»
How Parvus Therapeutics Inc. Discovered a New Class of Drugs
Jun 9, 2021 The path of development to clinical trials and commercialization to those drugs had already been blazed, while Santamaria and Parvus Therapeutics had to blaze their own trail. โฆSee details»
Genentech, Parvus In $800-Million-Plus Licensing Deal For โฆ
May 23, 2019 Rocheโs Genentech has entered into a global collaboration and licensing agreement with Parvus Therapeutics, a privately held biopharmaceutical company, to develop, โฆSee details»
News - Parvus Therapeutics Inc.
Parvus Therapeutics, a private clinical-stage biopharmaceutical company developing a pipeline of novel treatments for autoimmune disease announced the successful dosing of the first subject โฆSee details»